Orion: a glimpse of hope in life span extension?

Area of Science:

• Gerontology
• Pharmacology
• Drosophila melanogaster research

Background:

• Aging is a complex process influenced by genetics and environment.
• Taurocholic acid derivatives are components of various biological processes.
• Understanding interventions that promote longevity is crucial.

Purpose of the Study:

• To investigate the effects of a novel multicomponent drug, Orion, on lifespan and stress resistance in Drosophila melanogaster.
• To identify specific conditions and timings for Orion's efficacy.

Main Methods:

• Administration of Orion, a taurocholic acid derivative-based drug, to Drosophila melanogaster feeding medium.
• Assessment of lifespan extension and survival rates under various stress conditions (heat, acidic/alkaline pH, oxidative stress).
• Observation of age-dependent effects and induction of exceptionally long-lived individuals ('centenarian' flies).

Main Results:

• Orion significantly increased the lifespan of Drosophila melanogaster.
• Life extension was observed only when Orion was administered during the second half of the flies' lives ('age-threshold' effect).
• Orion enhanced survival under heat shock (38°C) and extreme pH conditions (1.6 and 11.8), but not under oxidative stress (100% oxygen or H2O2).
• The study identified 'centenarian' flies (older than 100 days) in the Orion-treated group.

Conclusions:

• Orion demonstrates potential as a pro-longevity agent in Drosophila melanogaster.
• The drug's efficacy is age-dependent, suggesting a specific window for intervention.
• Orion confers resistance to specific environmental stressors, highlighting a targeted protective mechanism.